| Literature DB >> 16339514 |
Adrian F Arechiga1, Bryan D Bell, Jennifer C Solomon, Isaac H Chu, Claire L Dubois, Brian E Hall, Thaddeus C George, David M Coder, Craig M Walsh.
Abstract
Recently, it has been demonstrated that stimulated T cells bearing defects in caspase-8 fail to promote nuclear shuttling of NF-kappaB complexes. Such cells display strikingly similar proliferative and survival defects as T cells lacking Fas-associated death domain protein (FADD) function. We characterized NF-kappaB signaling in T cells bearing a dominant-negative FADD transgene (FADDdd). Whereas FADDdd T cells displayed proliferative defects following activation, these were not a consequence of aberrant NF-kappaB signaling, as measured by IKK/IkappaB phosphorylation and IkappaB degradation. There were no appreciable defects in nuclear translocation of p65/Rel using ImageStream, a flow-based imaging cytometer. Pretreatment with benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, a potent caspase inhibitor, also failed to impede canonical NF-kappaB signaling. Secretion of IL-2 and up-regulation of various activation markers occurred normally. Thus, FADD does not play an essential role in NF-kappaB activation, suggesting an alternative route by which this adaptor promotes the clonal expansion of T cells.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16339514 DOI: 10.4049/jimmunol.175.12.7800
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422